Barbara Sibbald. Show Affiliations »
Abstract
Mesh： See more » Creutzfeldt-Jakob Syndrome/chemically inducedDrug and Narcotic Control/legislation & jurisprudenceErythropoietin/administration & dosageErythropoietin/adverse effectsErythropoietin/standardsHumansInjections, SubcutaneousKidney Failure, Chronic/drug therapyNorth AmericaRecombinant ProteinsRed-Cell Aplasia, Pure/chemically inducedRisk Assessment
Substances： See more » Recombinant ProteinsErythropoietin
Year: 2004 PMID： 14993165 PMCID： PMC343844 DOI： 10.1503/cmaj.1040210
Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262